| For: | Liu Y, Chang J, Bai LD. Intestinal flora: New perspective of type 2 diabetes. World J Clin Cases 2024; 12(11): 1996-1999 [PMID: 38660554 DOI: 10.12998/wjcc.v12.i11.1996] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v12/i11/1996.htm |
| Number | Citing Articles |
| 1 |
Yongqing Chen, Guangxu Wen, Hongmei Wang, Qiyu Yang, Zilang Luo, Xin Wang, Jing Ouyang, Jiadan Yang. Nomogram-based risk prediction model employing serum biomarkers to assess intestinal injury risk in patients with metabolic syndrome. Frontiers in Endocrinology 2025; 16 doi: 10.3389/fendo.2025.1579833
|
| 2 |
Tawhidul Islam, Nazim Uddin. Treatment of Type 2 Diabetes: A Comprehensive Review of Recent Improvements, Therapeutic Strategies, Challenges, and Future Perspectives. EMJ Diabetes 2025; : 72 doi: 10.33590/emjdiabet/RKYO7834
|
| 3 |
Yecheng Gao, Yanfang Liu, Zelong Li, Liyi Lu, Yajuan Guo, Dun Su, Heping Zhang, Promi Das. Multi-strain probiotics attenuate carbohydrate-lipid metabolic dysregulation in type 2 diabetic rats via gut-liver axis modulation. mSystems 2025; 10(7) doi: 10.1128/msystems.00369-25
|
